Although a causal role for low Trp levels in T cell inhibition cannot be fully discarded, the macrophage and Treg-dependent tumor progression detected in these models and its reversion upon AHR-blockade suggest that indirect TME-related mechanisms of T cell suppression drive IDO/TDO-mediated cancer progression through the AHR pathway. The gene discussed is AHR; the disease is neoplasm.